🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Camus Nimmo

London North West Healthcare NHS Trust

ORCID: 0000-0001-7355-4651

Also affiliated with University College London

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile
6.1Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis

The Lancet Microbe(2020)10.1016/s2666-5247(20)30031-8
Top 3%
6.1DataRank
Top 3%112 citations

James Millard, Lucy van Dorp, Kayleen Brien, Sashen Moodley, Allison Wolf +6 more

Papers

Driven by 7 papers — median percentile 97. Top paper: “Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis”.

Population-level emergence of bedaquiline and clofazimine resistance-associated variants among patients with drug-resistant tuberculosis in southern Africa: a phenotypic and phylogenetic analysis

The Lancet Microbe(2020)10.1016/s2666-5247(20)30031-8
Top 3%
6.1DataRank
Top 3%112 citations

James Millard, Lucy van Dorp, Kayleen Brien, Sashen Moodley, Allison Wolf +6 more

Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment

EBioMedicine(2020)10.1016/j.ebiom.2020.102747
N/A
0DataRank · unranked
90 citations

Kayleen Brien, James Millard, Alison D. Grant, Nesri Padayatchi, Alexander S. Pym +5 more

Dynamics of within-host Mycobacterium tuberculosis diversity and heteroresistance during treatment

medRxiv(2020)10.1101/2020.02.03.20019786
N/A
0DataRank · unranked
0 citations

Kayleen Brien, James Millard, Alison D. Grant, Nesri Padayatchi, Alexander S. Pym +5 more

Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB

Emerging infectious diseases(2023)10.3201/eid2905.221716
N/A
0DataRank · unranked
23 citations

Stephanie Rimmer, Camus Nimmo, Max R. O’Donnell, James Millard

Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: an individual isolate meta-analysis

medRxiv(2023)10.1101/2023.05.04.23289023
N/A
0DataRank · unranked
2 citations

Neda Bionghi, Matthew J. Cummings, Rubeshan Perumal, Madeleine Hopson, Shamim Al Jubaer +5 more

Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach

Nature Communications(2024)10.1038/s41467-023-44325-5
N/A
0DataRank · unranked
46 citations

Simone Battaglia, Emanuele Borroni, Angela Pires Brandão, Alice Brankin, Andrea Maurizio Cabibbe +95 more

Opportunities and limitations of genomics for diagnosing bedaquiline-resistant tuberculosis: a systematic review and individual isolate meta-analysis

The Lancet Microbe(2024)10.1016/s2666-5247(23)00317-8
N/A
0DataRank · unranked
14 citations

Neda Bionghi, Matthew J. Cummings, Rubeshan Perumal, Madeleine Hopson, Shamim Al Jubaer +6 more